Phase 3 Program: TRIUMPH Trials (20252026) The Phase 3 TRIUMPH investigational program is one of the most extensive registrational programs ever undertaken for a metabolic compound, with ongoing trials in obesity with comorbidities, type 2 diabetes, knee osteoarthritis, obstructive sleep apnea, chronic low back pain, cardiovascular outcomes, and MASLD
One SOD3 form (termed the type C subunit) interacts tightly with heparin in the extracellular matrix (ECM), the other (termed the type A subunit) does not interact with the extracellular matrix
The results indicated that GSH levels in blood increased significantly after one, three, and six months compared to baseline in both the low-dose and high-dose GSH groups, while no such increase was observed in the placebo group

TIER 0 (17mg total) $279 total for 8-10 week supply Monthly cost breakdown: $111-$139 based on weekly dose Recommended if using low (or micro) doses of 2mg/week or less TIER 1 (34mg total) $329 total for 8-10 week supply Monthly cost breakdown: $131-$164 based on weekly dose Recommended if new to treatment or for those on 2-4mg/week TIER 2 (51mg total) $389 total for 8-10 week supply Monthly cost breakdown: $155-$194 based on weekly dose Recommended for those on 5-6mg/week TIER 3 (102mg total) $459 total for 8-10 week supply Monthly cost breakdown: $183-$229 based on weekly dose Recommended for those on 7-12mg/week TIER 4 (136mg total) $519 total for 9-10 week supply Monthly cost breakdown: $207-$230 based on weekly dose Recommended for those on 13mg/week and up Strive Pharmacy - Tirzepatide/Glycine/B12 Injection Up to 90 days BUD
[22] [23] However, these mechanisms are primarily established in animal models with limited confirmation in human studies
J Cancer Res Clin Oncol 149 , 1524915273 (2023)